This Vaccines Congress will enhance our knowledge of the human immune response in health and disease, including news on discoveries of promising vaccine candidates for human diseases, viral immunology and immunopathogenesis. It will further encompass development and evaluation of vaccines, studies of vaccine vectors, quantitative assays of vaccine efficacy, and clinical trial studies illustrating new approaches for enhanced vaccine delivery for prophylactic and therapeutic application. Above all it will provide you with the knowledge from leading industry experts how you can boost your Vaccine R&D to lower cost and time to first dose, increase yield and optimise your vaccine pipeline to make it more attractive to potential investors.